Skip to main content

Year: 2023

Innofactor Plc: Share Repurchase 18.10.2023

Written by Customer Service on . Posted in Public Companies.

Innofactor Plc Announcement 18.10.2023          Innofactor Plc: Share Repurchase 18.10.2023       In the Helsinki Stock Exchange         Trade date 18.10.2023  Bourse trade Buy  Share IFA1V  Amount 4,100 SharesAverage price/ share 1.0583 EURTotal cost 4,339.03 EUR          Innofactor Plc now holds a total of 318 962 sharesincluding the shares repurchased on 18.10.2023          On behalf of Innofactor Plc         Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       Additional information:    Sami Ensio, CEO    Innofactor Plc    Tel. +358 50 584 2029    sami.ensio@innofactor.com         www.innofactor.com       AttachmentInnofactor_18.10_trades

Continue reading

Talenom Plc: Managers’ Transactions – Erik William Tahkola

Written by Customer Service on . Posted in Public Companies.

Talenom Plc, Managers’ Transactions 18 October 2023 at 18:30 EEST Talenom Plc: Managers’ Transactions – Erik William Tahkola_____________________________________ Person subject to the notification requirementName: Erik William TahkolaPosition: Member of the Board/Deputy memberIssuer: Talenom OyjLEI: 7437008E4R0N45B8J675 Notification type: INITIAL NOTIFICATIONReference number: 41038/5/4____________________________________________Transaction date: 2023-10-16Outside a trading venueInstrument type: SHAREISIN: FI4000153580Nature of transaction: GIFT,DONATION OR INHERITANCE (RECEIVED) Transaction details(1): Volume: 20000 Unit price: 0 EUR Aggregated transactions (1):Volume: 20000 Volume weighted average price: 0 EUR

Continue reading

Talenom Plc: Managers’ Transactions – Harri Tahkola

Written by Customer Service on . Posted in Public Companies.

Talenom Plc, Managers’ Transactions 18 October 2023 at 18:30 EEST Talenom Plc: Managers’ Transactions – Harri Tahkola____________________________________________ Person subject to the notification requirementName: Harri TahkolaPosition: Member of the Board/Deputy memberIssuer: Talenom OyjLEI: 7437008E4R0N45B8J675 Notification type: INITIAL NOTIFICATIONReference number: 41018/5/6____________________________________________ Transaction date: 2023-10-16Outside a trading venueInstrument type: SHAREISIN: FI4000153580Nature of transaction: GIFT,DONATION OR INHERITANCE (MADE) Transaction details(1): Volume: 20000 Unit price: 0 EUR(2): Volume: 20000 Unit price: 0 EUR(3): Volume: 20000 Unit price: 0 EUR(4): Volume: 20000 Unit price: 0 EUR(5): Volume: 20000 Unit price: 0 EUR(6): Volume: 20000 Unit price: 0 EUR Aggregated transactions...

Continue reading

NexImmune Announces 1-for-25 Reverse Stock Split

Written by Customer Service on . Posted in Public Companies.

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI) (the “Company”) a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today announced that the Board of Directors and stockholders of the Company approved a 1-for-25 reverse stock split of the Company’s common stock at a special meeting of the Company held on October 17, 2023. The reverse stock split will take effect after the close of trading on The Nasdaq Capital Market at 5:00 p.m. Eastern Time, on Wednesday, October 18, 2023. The Company’s common stock will open for trading under a new CUSIP number 65344D 208 on The Nasdaq Capital Market on October 19, 2023, on a split-adjusted...

Continue reading

TCM GROUP A/S releases preliminary Q3 numbers and downgrades outlook

Written by Customer Service on . Posted in Public Companies.

COMPANY ANNOUNCEMENT No. 181/2023         Tvis, 18. October 2023 TCM GROUP A/S releases preliminary Q3 numbers and downgrades outlook. TCM Group releases the preliminary financial numbers for Q3 2023 and downgrades the outlook for the financial year 2023. The downgrade is due to weaker trading conditions, increased provisions for accounts receivables, and a correction of estimates on transit-fees received from 3rd party suppliers pertaining to the financial year as a whole, including the first two quarters. Revenue in Q3 was DKK 258 million compared to DKK 265 million in Q3 last year, equal to a decline of 2.8%, where it should be noted that Aubo Production is consolidated in the financial figures from 3 July 2023 onwards. Adjusted EBIT in the quarter was DKK 3 million, with a material negative impact from the correction of third-party...

Continue reading

Aerostructures Market Set to Soar Past USD 101.01 Billion by 2030

Written by Customer Service on . Posted in Mergers And Acquisitions.

The global Aerostructures market size is expected to reach USD 101.01 billion by 2030 and exhibit a CAGR of 7.86% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for lightweight and fuel-efficient aircraft, growing air passenger traffic, rising defense budgets, advancements in composite materials and manufacturing techniques, expanding commercial aviation sector, adoption of additive manufacturing in aerostructures production, increasing focus on reducing aircraft emissions, modernization and retrofitting of existing aircraft, expanding aerospace and defense industry in emerging economies, are fueling the market’s growth. Westford USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Aerostructures market,  increased...

Continue reading

PD-1 And PD-L1 Inhibitors Market to Surpass 129.36 Billion by 2030 Drives Due to Immunotherapy Advancements

Written by Customer Service on . Posted in Mergers And Acquisitions.

SkyQuest projects that the PD-1 and PD-L1 inhibitors market will attain a USD 129.36 billion value by 2030, with a CAGR of 17.5% over the forecast period (2023-2030). The PD-1 and PD-L1 inhibitors market is fueled by rapid developments in immunotherapy, leveraging these inhibitors to enhance the body’s immune response against cancer. This innovation drives market growth as more precise and effective treatment options emerge. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, escalating global cancer incidences propel the demand for PD-1 and PD-L1 inhibitors. These inhibitors offer a promising avenue for patients seeking personalized and potent therapies, contributing to the PD-1 and PD-L1 inhibitors market’s expansion with their ability to target various cancer types. Browse In-Depth TOC on the...

Continue reading

Offshore Structural Analysis Software Market Set to Soar Past USD 1192.3 Million by 2030

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to the latest research by SkyQuest Technology, the Global Offshore Structural Analysis Software Market was valued at US$ 586.2 million in 2021, and it is expected to reach US$ 1192.3 million by 2030, with a CAGR of 9.13% during the forecast period of 2023-2030. The research provides up-to-date Offshore Structural Analysis Software market analysis of the current market landscape, latest trends, drivers, and overall market environment. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Offshore Structural Analysis Software market, when the offshore structural analysis is performed using cloud computing technology, the pre- and post-processing tasks are still carried out locally, but the model is delivered to the cloud platform for interpretation, freeing the customer...

Continue reading

Electromechanical Switch Market to Surpass 5.51 Billion by 2030 Drives Due toIncreased Automation

Written by Customer Service on . Posted in Mergers And Acquisitions.

SkyQuest projects that the electromechanical switch market will attain a value of USD 5.51 billion by 2030, with a CAGR of 3.20 % over the forecast period (2023-2030). The escalating trend of increased automation across various sectors notably propels the global electromechanical switch market. This surge in automation has led to the pivotal role of switches in regulating machine motions, emerging as a primary driving force for the market on a worldwide scale. Westford,USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the electromechanical switch market is witnessing a notable surge in demand, primarily attributed to the emergence of feature-rich automobiles. Especially prominent in vehicles equipped with advanced technologies such as Bluetooth and cellular connectivity, encoders have recently experienced remarkable...

Continue reading

Prescription Drugs Market to Surpass 2197 Billion by 2030 Drives Due to Growing Healthcare Needs

Written by Customer Service on . Posted in Mergers And Acquisitions.

SkyQuest projects that the prescription drugs market will attain a USD 2197 billion value by 2030, with a CAGR of 8.9% over the forecast period (2023-2030). The global prescription drugs market is propelled by the rising demand for medications driven by aging populations and the prevalence of chronic diseases. This necessitates a consistent supply of prescription drugs to manage health conditions effectively. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the relentless progress in pharmaceutical research and technology fuels the creation of groundbreaking drugs and therapies, broadening the prescription drugs market’s spectrum. This innovation effectively addresses various medical requirements, propelling the market’s growth while catering to diverse global healthcare needs.   Browse In-Depth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.